Renal tumors with clear cells. A review

Pathology Research and Practice

Volumn 209, Issue 3, 2013, Pages 137-146

  López, José I ^a  

^a BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE   (Spain)

Author keywords

Clear cell; Diagnosis; Differential diagnosis; Genetic disorder; Renal cancer

Indexed keywords

VON HIPPEL LINDAU PROTEIN;

ANGIOMYOLIPOMA; BIRT HOGG DUBE SYNDROME; CANCER CLASSIFICATION; CARCINOGENESIS; CHROMOSOME TRANSLOCATION 3; CHROMOSOME XP; CLEAR CELL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EPITHELIOID ANGIOMYOLIPOMA; FAMILIAL CANCER; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY TUMOR; MEDICAL TERMINOLOGY; NONHUMAN; PAPILLARY CARCINOMA; REVIEW; TUBEROUS SCLEROSIS; TUMOR CELL; VHL GENE; VON HIPPEL LINDAU DISEASE; WORLD HEALTH ORGANIZATION;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS;

EID: 84875381361     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.01.007     Document Type: Review

References (93)

1. Abrahams N.A., Tamboli P. Oncocytic renal neoplasms: diagnostic considerations. Clin. Lab. Med. 2005, 25:317-339.
2. Al-Saleem T., Cairns P., Dulaimi E.A., Feder M., Testa J.R., Uzzo R.G. The genetics of renal oncocytosis: a possible model for neoplastic progression. Cancer Genet. Cytogenet. 2004, 152:23-28.
3. Altinok G., Kattar M.M., Mohamed A., et al. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations. Pediatr. Dev. Pathol. 2005, 8:168-180.
4. Anglard P., Troy K., Brauch H., et al. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res. 1991, 51:1071-1077.
5. Argani P., Lae M., Ballard E.T., et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J. Clin. Oncol. 2006, 24:1529-1534.
6. Argani P., Antonescu C.R., Couturier J., et al. PRCC-TFE3 renal cell carcinomas: morphologic, immunohistochemical, ultrastructural and molecular analysis o fan entity associated with the t(X;1)(p11.2;q21). Am. J. Surg. Pathol. 2002, 26:1553-1566.
7. Argani P., Antonescu C.R., Illei P.B., et al. Primary renal neoplasms with the ASLP-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am. J. Pathol. 2001, 159:179-192.
8. Argani P., Hawkins A., Griffin C.A., et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am. J. Pathol. 2001, 158:2089-2096.
9. Argani P., Ladanyi M. The evolving story of renal translocation carcinomas. Am. J. Clin. Pathol. 2006, 126:332-334.
10. Argani P., Ladanyi M. Translocation carcinomas of the kidney. Clin. Lab. Med. 2005, 25:363-378.
11. Argani P., Lae M., Hutchison B., et al. Renal carcinomas with the t(6;11)(p21;q12). Clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am. J. Surg. Pathol. 2005, 29:230-240.
12. Argani P., Olgac S., Tickoo S., et al. Adult Xp11 translocation renal cell carcinoma (RCC): expanded clinical, pathologic, and genetic spectrum. Lab. Invest. 2007, 87:135A.
13. Aydin H., Chen L., Cheng L., et al. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am. J. Surg. Pathol. 2010, 34:1608-1621.
14. Aydin H., Magi-Galluzzi C., Lane B.R., et al. Renal angiomyolipoma: clinicopathological study of 194 cases with emphasis on the epithelioid histology and Tuberous Sclerosis association. Am. J. Surg. Pathol. 2009, 33:289-297.
15. Bader H.L., Hsu T. Systemic VHL gene functions and the VHL disease. FEBS Lett. 2012, 586:1562-1569.
16. Birt A., Hogg G.R., Dubé W.J. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch. Dermatol. 1997, 113:1674-1677.
17. Bjornsson J., Short M.P., Kwiatkowski D.J., et al. Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am. J. Pathol. 1996, 149:1201-1208.
18. Bottaro D.P., Linehan W.M. Multifocal renal cancer: genetic basis and its medical relevance. Clin. Cancer Res. 2005, 11:7206-7208.
19. Brimo F., Robinson B., Guo C., et al. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am. J. Surg. Pathol. 2010, 34:715-722.
20. Bruder E., Passera O., Harms D., et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am. J. Surg. Pathol. 2004, 28:1117-1132.
21. Brunelli M., Eble J.N., Zhang S., et al. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Mod. Pathol. 2003, 16:1060-1063.
22. Chian-Garcia C.A., Torres-Cabala C.A., Eyler R., et al. Renal cell carcinoma in children and young adults: a clinicopathologic and immunohistochemical study of 14 cases. Mod. Pathol. 2003, 16:145A.
23. Chow W.H., Devesa S.S., Warren J.L., et al. Rising incidence of renal cell cancer in the United States. JAMA 1999, 281:1628-1631.
24. Choyke P., Walther M., Glenn G. Imaging features of hereditary papillary renal cancers. J. Comput. Assist. Tomogr. 1997, 21:737-741.
25. Clark P.E. The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy. Kidney Int. 2009, 76:939-945.
26. Clark J., Lu Y.L., Sidhar S.K., et al. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 1997, 15:2233-2239.
27. Cohen A.J., Li F.P., Berg S., et al. Hereditary renal cell carcinoma associated with a chromosomal translocation. N. Engl. J. Med. 1979, 301:592-595.
28. Cohen D., Zhou M. Molecular genetics of familial renal cell carcinomas syndromes. Clin. Lab. Med. 2005, 25:259-277.
29. Cossu-Rocca P., Eble J.N., Zhang S., Martignoni G., Brunelli M., Cheng L. Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod. Pathol. 2006, 19:780-787.
30. Davis I.J., His B.L., Arroyo J.D., et al. Cloning of a novel alpha-TFEB fusion in renal tumors harbouring the t(6;11)(p21;q12) chromosome translocation. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:6051-6056.
31. Di Renzo M.F., Narsimhan R.P., Olivero M., et al. Expresión of the Met/HGF receptor in normal and neoplastic human tisúes. Oncogene 1991, 6:1997-2003.
32. Dijkhuizen T., ven den Berg E., Störkel S., et al. Two cases of renal cell carcinoma, clear cell type, revealing t(6;11)(p21;q12). Cancer Genet. Cytogenet. 1996, 91:141.
33. Tumours of the Kidney. World Health Organization Classification of Tumours: Pathology and Genetics, Tumours of the Urinary System and Male Genital Organs 2004, 9-43. IARC Press, Lyon. J.N. Eble, G. Sauter, J.I. Epstein (Eds.).
34. European Chromosome 16 Tuberous Sclerosis Consortium Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993, 75:1305-1315.
35. Farber L.J., Furge K., Teh B.T. Renal cell carcinoma deep sequencing: recent developments. Curr. Oncol. Rep. 2012, 14:240-248.
36. Fine S.W., Reuter V.E., Epstein J.I., et al. Angiomyolipoma with epithelial cysts (AMLEC). A distinct cystic variant of angiomyolipoma. Am. J. Surg. Pathol. 2006, 30:593-599.
37. Fingar D.C., Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004, 23:3151-3171.
38. Fletcher C.D.M. Diagnostic Histopathology of Tumors 2000, Churchill Livingstone, London. 2nd ed.
39. Foster K., Prowse A., van der Berg A., et al. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum. Mol. Genet. 1994, 3:2169-2173.
40. Fuhrman S.A., Lasky L.C., Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 1982, 6:655-663.
41. Gemmill R.M., Bemis L.T., Lee J.P., et al. The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL common pathway. Oncogene 2002, 21:3507-3516.
42. Gossage L., Eisen T. Alterations in VHL as potential biomarkers in renal-cell carcinoma. Nat. Rev. Clin. Oncol. 2010, 7:277-288.
43. Grignon D.J., Che M. Clear cell renal cell carcinoma. Clin. Lab. Med. 2005, 25:305-316.
44. Henske E.P. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatr. Nephrol. 2005, 20:854-857.
45. Jonasch E., Futreal P.A., Davis I.J., et al. State of the science: an update on renal cell carcinoma. Mol. Cancer Res. 2012, 10:859-880.
46. Khoo S.K., Bradley M., Wong F.K., et al. Birt-Hogg-Dubé syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2. Oncogene 2001, 20:5239-5242.
47. Khoo S.K., Kahnoski K., Sugimura J., et al. Inactivation of BHD in sporadic renal tumors. Cancer Res. 2003, 63:4583-4587.
48. Kim W.Y., Kaelin W.G. Role of VHL gene mutation in human cancer. J. Clin. Oncol. 2004, 22:4991-5004.
49. Kojima Y., Takahara S., Miyake O., Nonomura N., Morimoto A., Mori H. Renal cell carcinoma in dialysis patients: a single center experience. Int. J. Urol. 2006, 13:1045-1048.
50. Kuroda N., Mikami S., Pan C.C., et al. Review of renal carcinoma associated with Xp11 translocations/TFE3 gene fusions with focus on pathobiological aspect. Histol. Histopathol. 2012, 27:133-140.
51. Kuroda N., Ohe C., Mikami S., et al. Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol. Histopathol. 2012, 27:969-974.
52. Lubensky I.A., Schmidt L., Zhuang Z. Hereditary and sporadic papillary renal cell carcinomas with c-met mutations share a distinct morphological phenotype. Am. J. Pathol. 1999, 155:517-526.
53. Maher E.R., Kaelin W.G. von Hippel-Lindau disease. Medicine (Bal) 1997, 76:381-391.
54. Mete O., van der Kwast T.H. Epithelioid angiomyolipoma. A morphologically distinct variant that mimics a variety of intra-abdominal neoplasms. Arch. Pathol. Lab. Med. 2011, 135:665-670.
55. Moch H. Funktionen des VHL-Proteins bei Entstehung und Progression von Nierenzellkarzinomen. Pathologe 2008, 29(Suppl. 2):149-152.
56. Nese N., Martignoni G., Fletcher C.D., et al. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am. J. Surg. Pathol. 2011, 35:161-176.
57. Novara G., Martignoni G., Artibani W., Ficarra V. Grading systems in renal cell carcinoma. J. Urol. 2007, 177:430-436.
58. Nyhan M.J., O'Sullivan G.C., McKenna S.L. Role of the VHL(von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor. Biochem. Soc. Trans. 2008, 36:472-478.
59. O'Callaghan F.J.K., Shiell A.W., Osborne J.P., et al. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet 1998, 351:1490.
60. Ohta M., Inoue H., Cotticelli M.G., et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal cell carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84:587-597.
61. Onishi T., Oishi Y., Yanada S., Abe K., Hasegawa T., Maeda S. Prognostic implications of histological features in patients with chromophobe cell renal carcinoma. BJU Int. 2002, 90:529-532.
62. Park S., Cadeddu J.A., Shingleton W.B. Oncologic outcomes for ablative therapy of kidney cancer. Curr. Urol. Rep. 2007, 8:31-37.
63. Pavlovich C.P., Walther M.M., Eyler R.A., et al. Renal tumors in the Birt-Hogg-Dubé syndrome. Am. J. Surg. Pathol. 2002, 26:1542-1552.
64. Ponzetto C., Pante G., Prunotto C., et al. Met signaling mutants as tools for developmental studies. Int. J. Dev. Biol. 2000, 44:645-653.
65. Pope J.C., Koch M.O., Bluth R.F. Renal cell carcinoma in patients with end-stage renal disease: a comparison of clinical significance in patients receiving hemodialysis and those with renal transplants. Urology 1994, 44:497-501.
66. Rathmell W.K., Chen S. VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment. Expert Rev. Anticancer Ther. 2008, 8:63-73.
67. Rioux-Leclercq N., Karakiewicz P.I., Trinh Q.D., et al. Prognostic ability of simplified nuclear grading on renal cell carcinoma. Cancer 2007, 109:868-874.
68. Robertson F.M., Cendron M., Klauber G.T., et al. Renal cell carcinoma in association with tuberous sclerosis in children. J. Pediatr. Surg. 1996, 31:729-730.
69. Rosai J. Rosai and Ackerman's Surgical Pathology 2004, Mosby, Edinburgh. 9th ed.
70. Ross H., Martignoni G., Argani P. Renal cell carcinoma with clear cell and papillary features. Arch. Pathol. Lab. Med. 2012, 136:391-399.
71. Salido M., Lloreta J., Melero C., et al. Insertion (8;11) in a renal oncocytoma with multifocal transformation to chromophobe renal cell carcinoma. Cancer Genet. Cytogenet. 2005, 163:160-163.
72. Schmidt L., Duh F.M., Chen F., et al. Germline and somatic mutationsin the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 1997, 16:68-73.
73. Schmidt L., Junker K., Nakaigawa N., et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 1999, 18:2343-2350.
74. Schmidt L.S., Nickerson M.L., Angeloni D., et al. Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene. J. Urol. 2004, 172:1256-1261.
75. Schraml P., Struckmann K., Hatz F., et al. VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma. J. Pathol. 2002, 196:186-193.
76. Seizinger B.R., Rouleau G.A., Ozelius L.J., et al. von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 1988, 332:268-269.
77. Shuch B., Singer E.A., Bratslavsky G. The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors. Urol. Clin. North Am. 2012, 39:133-148.
78. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA. Cancer J. Clin. 2012, 62:10-29.
79. Sufan R.I., Jewett M.A.S., Ohh M. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma. Am. J. Physiol. Renal Physiol. 2004, 287:1-6.
80. Teh B.T., Giraud S., Sari N.F., et al. Familial non-VHL non-papillary clear-cell renal cancer. Lancet 1997, 349:848-849.
81. Thoenes W., Störkel S., Rumpelt H.J. Histopathology and classification of renal cell tumors (adenomas, oncocytomas, and carcinomas). Pathol. Res. Pract. 1986, 181:125-143.
82. Tickoo S.K., de Peralta-Venturina M.N., Harik L.R., et al. Spectrum of epithelial neoplasms in end-stage renal disease. An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am. J. Surg. Pathol. 2006, 30:141-153.
83. Truong L.D., Choi Y.J., Shen S.S., Ayala G., Amato R., Krishnan B. Renal cystic neoplasms and renal neoplasms associated with cystic renal diseases: pathogenetic and molecular links. Adv. Anat. Pathol. 2003, 10:135-159.
84. van Kessel A.G., Wijnhoven H., Bodmer D., et al. Renal cell cancer: chromosome 3 translocations and risk factors. J. Natl. Cancer Inst. 1999, 91:1159-1160.
85. van Slegtenhorst M., de Hoogt R., Hermans C., et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997, 277:805-808.
86. Walter B., Hartmann A., Hofstädter F., et al. Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria. Virchows Arch. 2012, 460:343-352.
87. Wolfe A., Dobin S.M., Grossmann P., et al. Clonal trisomies 7, 10, and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney. Virchows Arch. 2011, 459:457-463.
88. Yang L., Feng X.L., Shen S., et al. Clinicopathological analysis of 156 patients with angiomyolipoma originating from different organs. Oncol. Lett. 2012, 3:586-590.
89. Yoshida M.A., Ohyashiki K., Ochi H., et al. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res. 1986, 46:2139-2147.
90. Yoshida S.O., Imam A., Olson C.A., et al. Proximal renal tubular surface membrane antigens identified in primary and metastatic renal cell carcinomas. Arch. Pathol. Lab. Med. 1986, 110:825-832.
91. Zbar B., Kishida T., Chen F., et al. Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe and Japan. Hum. Mutat. 1996, 8:348-357.
92. Zhong M., De Angelo P., Osborne L., et al. Translocation renal cell carcinoma in adults: a single-institution experience. Am. J. Surg. Pathol. 2012, 36:654-662.
93. Zhou M., Roma A., Magi-Galluzzi C. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin. Lab. Med. 2005, 25:247-257.